Dr. Anas Younes MD Medical Oncologist
Dr. Anas Younes is a medical oncologist in Houston, Texas and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Damascus University Faculty of Medicine and has been in practice for 31 years. Dr. Younes accepts several types of health insurance, listed below. He is one of 129 doctors at University of Texas M.D. Anderson Cancer Center who specialize in Medical Oncology.
Are you Dr. Anas Younes? Claim your profile to make edits or add details. Edit Profile
Specialty & Clinical Interests
Medical Oncologist: Hematologic
Clinical Interests: Hodgkin and non-Hodgkin lymphoma, Antineoplastic Agents, Hodgkin Disease, Disease-Free Survival, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols, Mantle-Cell Lymphoma, Recurrence, Maximum Tolerated Dose
University of Texas M.D. Anderson Cancer Center
Ranked #1 in Cancer
Education & Medical Training
SUNY Health Science Center at Brooklyn
Residency, Internal Medicine, 1989
Medical College of Ohio at Toledo
Residency, Anatomic and Clinical Pathology, 1985 - 1986
Memorial Sloan-Kettering Cancer Center
Damascus University Faculty of Medicine
Class of 1983
Certifications & Licensure
American Board of Pediatrics
Certified 21 years in Pediatrics
American Board of Pediatrics
Certified 8 years in Developmental-Behavioral Pediatrics
MA State Medical License
Active through 2014
FL State Medical License
Active through 2015
Publications & Presentations
Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy.
Gopal, A. K.,Bartlett, N. L.,Forero-Torres, A.,Younes, A.,Chen, R.,Friedberg, J. W.,Matous, J. V.,Shustov, A. R.,Smith, S. E.,Zain, J.,O'Meara, M. M.,Fanale, M. A.
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
Oki, Y.,Chuang, H.,Chasen, B.,Jessop, A.,Pan, T.,Fanale, M.,Dabaja, B.,Fowler, N.,Romaguera, J.,Fayad, L.,Hagemeister, F.,Alma Rodriguez, M.,Neelapu, S.,Samaniego, F.,Kwak, L.,Younes, A.
Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
Oki, Y.,Westin, J. R.,Vega, F.,Chuang, H.,Fowler, N.,Neelapu, S.,Hagemeister, F. B.,McLaughlin, P.,Kwak, L. W.,Romaguera, J. E.,Fanale, M.,Younes, A.,Rodriguez, M. A.,Orlowski, R. Z.,Wang, M.,Ouzounian, S. T.,Samaniego, F.,Fayad, L.
- Aetna Choice POS II
- Aetna HMO
- CIGNA HMO
- CIGNA Open Access
- CIGNA PPO
- Great West PPO
- Horizon BCBS Direct Access
- Horizon BCBS HMO
- Horizon BCBS POS
- Horizon BCBS PPO
- Humana ChoiceCare Network PPO
- United Healthcare - Direct Choice Plus POS
- United Healthcare - Direct Options PPO
Help Us Keep the "U.S. News Doctor Finder" Current
If you are aware of information on this pagethat is out of date or incorrect, please let us know.
*Required Field | Your email will not be used for marketing.
Your Message Has Been Submitted
As part of our research on the correction you submitted, you may be contacted at the email address provided.
Sorry, Your Message Could Not Be Submitted
Please try again later, or E-mail your message to email@example.com and include the Web address (URL) of the page that contains incorrect information.
1515 Holcombe Blvd
Houston, TX 77030
Phone: (713) 792-6161